These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 26456732)

  • 1. Leukotriene C4 increases the susceptibility of adult mice to Shiga toxin-producing Escherichia coli infection.
    Cabrera G; Fernández-Brando RJ; Mejías MP; Ramos MV; Abrey-Recalde MJ; Vanzulli S; Vermeulen M; Palermo MS
    Int J Med Microbiol; 2015 Dec; 305(8):910-7. PubMed ID: 26456732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenic role of inflammatory response during Shiga toxin-associated hemolytic uremic syndrome (HUS).
    Exeni RA; Fernandez-Brando RJ; Santiago AP; Fiorentino GA; Exeni AM; Ramos MV; Palermo MS
    Pediatr Nephrol; 2018 Nov; 33(11):2057-2071. PubMed ID: 29372302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dextran Sulfate Sodium Colitis Facilitates Colonization with Shiga Toxin-Producing Escherichia coli: a Novel Murine Model for the Study of Shiga Toxicosis.
    Hall G; Kurosawa S; Stearns-Kurosawa DJ
    Infect Immun; 2018 Nov; 86(11):. PubMed ID: 30150257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An epidemiologic surveillance of Shiga-like toxin-producing Escherichia coli infection in Argentinean children: risk factors and serum Shiga-like toxin 2 values.
    López EL; Contrini MM; Glatstein E; Ayala SG; Santoro R; Ezcurra G; Teplitz E; Matsumoto Y; Sato H; Sakai K; Katsuura Y; Hoshide S; Morita T; Harning R; Brookman S
    Pediatr Infect Dis J; 2012 Jan; 31(1):20-4. PubMed ID: 21829137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shiga toxin production and translocation during microaerobic human colonic infection with Shiga toxin-producing E. coli O157:H7 and O104:H4.
    Tran SL; Billoud L; Lewis SB; Phillips AD; Schüller S
    Cell Microbiol; 2014 Aug; 16(8):1255-66. PubMed ID: 24612002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental In Vivo Models of Bacterial Shiga Toxin-Associated Hemolytic Uremic Syndrome.
    Jeong YJ; Park SK; Yoon SJ; Park YJ; Lee MS
    J Microbiol Biotechnol; 2018 Sep; 28(9):1413-1425. PubMed ID: 29926707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenesis of Shiga-toxin producing escherichia coli.
    Melton-Celsa A; Mohawk K; Teel L; O'Brien A
    Curr Top Microbiol Immunol; 2012; 357():67-103. PubMed ID: 21915773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in pathogenesis and therapy of hemolytic uremic syndrome caused by Shiga toxin-2.
    Ibarra C; Amaral MM; Palermo MS
    IUBMB Life; 2013 Oct; 65(10):827-35. PubMed ID: 24014500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemolytic uremic syndrome with mild renal involvement due to Shiga toxin-producing Escherichia coli (STEC) O145 strain.
    Pérez L; Apezteguía L; Piñeyrúa C; Dabezies A; Bianco MN; Schelotto F; Varela G
    Rev Argent Microbiol; 2014; 46(2):103-6. PubMed ID: 25011592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Citrobacter rodentium Lysogenized with a Shiga Toxin-Producing Phage: A Murine Model for Shiga Toxin-Producing E. coli Infection.
    Flowers LJ; Hu S; Shrestha A; Martinot AJ; Leong JM; Osburne MS
    Methods Mol Biol; 2021; 2291():381-397. PubMed ID: 33704765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neonatal hemolytic uremic syndrome after mother-to-child transmission of a low-pathogenic stx2b harboring shiga toxin-producing Escherichia coli.
    Stritt A; Tschumi S; Kottanattu L; Bucher BS; Steinmann M; von Steiger N; Stephan R; Hächler H; Simonetti GD
    Clin Infect Dis; 2013 Jan; 56(1):114-6. PubMed ID: 23042969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infections in pediatric postdiarrheal hemolytic uremic syndrome: factors associated with identifying shiga toxin-producing Escherichia coli.
    Mody RK; Luna-Gierke RE; Jones TF; Comstock N; Hurd S; Scheftel J; Lathrop S; Smith G; Palmer A; Strockbine N; Talkington D; Mahon BE; Hoekstra RM; Griffin PM
    Arch Pediatr Adolesc Med; 2012 Oct; 166(10):902-9. PubMed ID: 22869280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenovirus vector expressing Stx1/Stx2-neutralizing agent protects piglets infected with Escherichia coli O157:H7 against fatal systemic intoxication.
    Sheoran AS; Dmitriev IP; Kashentseva EA; Cohen O; Mukherjee J; Debatis M; Shearer J; Tremblay JM; Beamer G; Curiel DT; Shoemaker CB; Tzipori S
    Infect Immun; 2015 Jan; 83(1):286-91. PubMed ID: 25368111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of Shiga-toxigenic Escherichia coli isolated from cases of diarrhoea & haemolytic uremic syndrome in north India.
    Kumar A; Taneja N; Bharti B; Sharma M
    Indian J Med Res; 2014 Dec; 140(6):778-84. PubMed ID: 25758577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemolytic uremic syndrome: differential diagnosis with the onset of inflammatory bowel diseases.
    Bianchi L; Gaiani F; Vincenzi F; Kayali S; Di Mario F; Leandro G; De' Angelis GL; Ruberto C
    Acta Biomed; 2018 Dec; 89(9-S):153-157. PubMed ID: 30561409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic strategies for Shiga toxin-producing Escherichia coli infections.
    Rogers TJ; Paton JC
    Expert Rev Anti Infect Ther; 2009 Aug; 7(6):683-6. PubMed ID: 19681694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human monocytes stimulated by Shiga toxin 1a via globotriaosylceramide release proinflammatory molecules associated with hemolytic uremic syndrome.
    Brigotti M; Carnicelli D; Arfilli V; Porcellini E; Galassi E; Valerii MC; Spisni E
    Int J Med Microbiol; 2018 Oct; 308(7):940-946. PubMed ID: 29983334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gut-Kidney Axis on Chip for Studying Effects of Antibiotics on Risk of Hemolytic Uremic Syndrome by Shiga Toxin-Producing
    Lee Y; Kim MH; Alves DR; Kim S; Lee LP; Sung JH; Park S
    Toxins (Basel); 2021 Nov; 13(11):. PubMed ID: 34822559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bacterial genetic determinants of non-O157 STEC outbreaks and hemolytic-uremic syndrome after infection.
    Wickham ME; Lupp C; Mascarenhas M; Vazquez A; Coombes BK; Brown NF; Coburn BA; Deng W; Puente JL; Karmali MA; Finlay BB
    J Infect Dis; 2006 Sep; 194(6):819-27. PubMed ID: 16941350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between azithromycin therapy and duration of bacterial shedding among patients with Shiga toxin-producing enteroaggregative Escherichia coli O104:H4.
    Nitschke M; Sayk F; Härtel C; Roseland RT; Hauswaldt S; Steinhoff J; Fellermann K; Derad I; Wellhöner P; Büning J; Tiemer B; Katalinic A; Rupp J; Lehnert H; Solbach W; Knobloch JK
    JAMA; 2012 Mar; 307(10):1046-52. PubMed ID: 22416100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.